Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Thumbnail

Tracking PCI readmissions may improve value of cardiology care

As of now, readmissions after PCIs are not publicly reported in the U.S. Still, a pilot program may serve as a model for the future as physicians and payers focus more on the value of cardiology care.

Cleveland Clinic cardiac surgeons implant first Perceval sutureless heart valves in the U.S.

Douglas Johnson, MD, and Eric Roselli, MD, staff cardiac surgeons at the Cleveland Clinic’s Miller Family Heart & Vascular Institute, recently performed the first implantations in the U.S. of the Perceval sutureless heart valve.

Medtronic announces real world study of the CoreValve Evolut R system

Medtronic announced on March 7 that the first patients had enrolled in a clinical trial to test the performance of the CoreValve Evolut R system in a real world setting.

FDA expands approval of Sapien XT transcatheter heart valve

The FDA expanded the approval of the Sapien XT transcatheter heart valve on March 2 to include pulmonic valve replacement procedures.

Thumbnail

Bioresorbable Scaffolds: Lingering Challenges for a Device that Goes Away

Will noninferior results be good enough to win over cardiologists and payers?

Thumbnail

Inside the Cath Lab: Tracking Supplies, Cutting Costs

Cardinal Health

Balancing needs, utilization and cost while improving patient care are central to the mission of the interventional cardiology team at Emory Saint Joseph’s Hospital in Atlanta.

Statin use does not reduce risk of acute kidney injury following cardiac surgery

Adults who received atorvastatin before, during and after cardiac surgery did not have a reduction in the risk of acute kidney injury compared with a placebo group, according to a double-blinded, placebo-controlled, randomized trial.

High-dose tirofiban during PCI is associated with significant reduction in all-cause mortality

A meta-analysis of 41 randomized clinical trials found that patients who received high-dose bolus tirofiban (Aggrastat, Medicure, Inc.) during PCI had a significant reduction in all-cause mortality compared with those who received eptifibatide or heparin.

Displaying 1433 - 1440 of 2710

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.